Consumption of antiretroviral drugs in the Republic of Kazakhstan
Narkevich I.A. Nemyatykh O.D. Medvedeva D.M. Akpaeva K.M. Sakipova Z.B. Shukirbekova A.B. Mironenkova Z.V.
2022Media Sphera Publishing Group
Medical Technologies. Assessment and Choice
2022#2022Issue 222 - 32 pp.
Objective. To evaluate consumption of antiretroviral drugs in the Republic of Kazakhstan. Material and methods. We analyzed data of the analytical agency IQVIA for the period from 2014 to 2020. Comparative analysis methods, time series and ATC/DDD methodology were applied. Results. Analysis of the Kazakh and international practices of antiretroviral therapy suggests that certain drugs used abroad includ-ing nucleoside reverse transcriptase inhibitors (NRTIs), protease inhibitors (PIs), integrase inhibitors (IIs) and CCR5 receptor antag-onists are not included in assortment matrix determining pharmacotherapy of HIV-infected patients in the Republic of Kazakhstan. Assessment of antiretroviral drug consumption indicates increase of therapy availability that is expressed in increment of the vol-ume of realized demand in physical terms by 84% in the context of decrease in sales in value terms by 17%. Structuring of antiret-roviral drug consumption by producing countries showed that foreign pharmaceutical companies (the United States in value terms (52%), India in natural units (62%)) make the maximum contribution to sale structure. Assessment of consumption in each phar-macotherapeutic group demonstrates predominance of combined ARV therapy containing 2 NRTIs and 1 NNRTI and combined therapy containing 2 NRTIs in physical terms and PI with II in value terms. The Republic of Kazakhstan complies with the WHO recommendations on minimizing the drug resistance of HIV to antiretroviral therapy. Conclusion. The obtained results substantiate further research in improving the drug supply of patients with HIV infection aimed at expanding the national portfolio of antiretroviral drugs.
antiretroviral therapy , ATC/DDD methodology , drug provision , HIV-infection
Text of the article Перейти на текст статьи
St. Petersburg State Chemical Pharmaceutical University, St. Petersburg, Russian Federation
Astana Medical University, Nur-Sultan, Kazakhstan
Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
St. Petersburg State Chemical Pharmaceutical University
Astana Medical University
Asfendiyarov Kazakh National Medical University
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026